Concepedia

J A Kemp

JA

14

Publications

3.1K

Citations

13

H-Index

1986

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (UK) Limited (United Kingdom)

Royal Veterinary College

J A Kemp is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, neuropharmacology, and pharmacology.

Top concepts

Publications per year

1986–1995

14

Publications

14

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist.

Erik H.F. Wong, J A Kemp, Tony Priestley et al. · Proceedings of the National Academy of Sciences · 1986 · 1.8K citations · Full text

, , +18

Role of the beta subunit in determining the pharmacology of human gamma-aminobutyric acid type A receptors.

Karen L. Hadingham, Peter B. Wingrove, Keith A. Wafford et al. · Molecular Pharmacology · 1993 · 201 citations

Molecular pharmacology of gamma-aminobutyric acid type A receptor agonists and partial agonists in oocytes injected with different alpha, beta, and gamma receptor subunit combinations.

Bjarke Ebert, Keith A. Wafford, Paul J. Whiting et al. · Molecular Pharmacology · 1994 · 176 citations

Differences in affinity and efficacy of benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes.

Keith A. Wafford, Paul J. Whiting, J A Kemp · Molecular Pharmacology · 1993 · 154 citations

Functional comparison of the role of gamma subunits in recombinant human gamma-aminobutyric acidA/benzodiazepine receptors.

Keith A. Wafford, C Bain, Paul J. Whiting et al. · Molecular Pharmacology · 1993 · 147 citations

Rows per page

1–5 of 14